Dermata Therapeutics, Inc. [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19
	10-K	10-K	S-1
Revenues [+]	0.2	0.0	4.5
Net interest income	0.2
Revenue growth		-100.0%
Cost of goods sold	0.2	0.0	4.5
Gross profit	0.0	0.0	0.0
Gross margin	0.0%		0.7%
Selling, general and administrative [+]	4.4	1.6	1.8
General and administrative	4.4	1.6	1.8
Research and development	3.5	1.6	2.6
Other operating expenses			0.0
EBITDA [+]		-3.2	-4.5
EBITDA growth	147.7%	-29.0%
EBITDA margin	-4354.4%		-99.3%
Depreciation and amortization		0.0	0.0
EBIT [+]	-7.9	-3.2	-4.5
EBIT growth	147.6%	-29.0%
EBIT margin	-4354.4%		-99.3%
Interest expense	0.0	0.2	0.3
Interest expense	0.0	0.2	0.3
Other income (expense), net		0.1
Pre-tax income	-7.9	-3.2	-4.7
Income taxes	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-10.5	-3.2	-4.7
Net margin	-5799.7%		-104.8%

Basic EPS [+]	($2.43)	($1.69)	($2.47)
Growth	43.6%	-31.4%
Diluted EPS [+]	($2.43)	($1.69)	($2.47)
Growth	43.6%	-31.4%

Shares outstanding (basic) [+]	4.3	1.9	1.9
Growth	125.1%	0.0%
Shares outstanding (diluted) [+]	4.3	1.9	1.9
Growth	125.1%	0.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.